Several breakthroughs in hepatocellular carcinoma (HCC) therapy across tumor stages
provide hope to improve its dismal prognosis. Although surgical and local ablative therapies …

Summary This Expert Opinion article thoroughly analyses the Barcelona Clinic Liver Cancer
(BCLC) staging and treatment algorithm for hepatocellular carcinoma (HCC) that, since …

Hepatocellular carcinoma (HCC) is refractory to treatment under the following conditions:(A)
a large number of tumors,(B) large tumor size,(C) vascular invasion or extrahepatic spread …

The treatment outcomes of patients with hepatocellular carcinoma (HCC) in Japan have
improved dramatically over the past 40 years and are probably the best in the world …

Recent advances in systemic therapy for hepatocellular carcinoma (HCC) have been
remarkable. Systemic therapies were initially developed for advanced HCC. Today …

PURPOSE Durable partial response (PR) and durable stable disease (SD) are often seen in
patients with hepatocellular carcinoma (HCC) receiving atezolizumab plus bevacizumab …

Simple Summary Immunotherapy for hepatocellular carcinoma (HCC) is progressing rapidly.
In particular, analyses of the tumor immune environment in HCC are progressing. Moreover …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality in India. This
review explores the epidemiological trends and the landscape of systemic therapy for HCC …

Background This study aimed to determine whether salvage hepatectomy offers prognostic
advantages for unresectable hepatocellular carcinoma (uHCC) patients with clinical …

Background To identify predictive factors associated with successful transition to conversion
therapy following combination therapy with atezolizumab and bevacizumab in the treatment …